Hepatocellular carcinoma: global epidemiology.
Tabor
E
E
Office of Blood Research and Review, Food and Drug Administration, Rockville, MD 20852-1448, USA. tabor@cber.fda.gov
D000328:Adult; D017677:Age Distribution; D006528:Carcinoma, Hepatocellular / Q000175:diagnosis / Q000453:epidemiology*; D015897:Comorbidity; D005260:Female; D014943:Global Health; D019694:Hepatitis B, Chronic / Q000175:diagnosis / Q000453:epidemiology*; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000453:epidemiology*; D006801:Humans; D015994:Incidence; D008103:Liver Cirrhosis / Q000175:diagnosis / Q000453:epidemiology*; D008113:Liver Neoplasms / Q000175:diagnosis / Q000453:epidemiology*; D008297:Male; D008875:Middle Aged; D018570:Risk Assessment; D017678:Sex Distribution; D015996:Survival Rate; D014944:World Health Organization